22 May 2013
Keywords: strong, maintenance, data, olanzapine, lai, drug, major
Article | 15 September 2008
US drug major Eli Lilly's investigational olanzapine long-acting injection therapeutic showed a maintenance of treatment benefit in a
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 September 2008
8 September 2008
22 September 2008
© 2013 thepharmaletter.com